Results 21 to 30 of about 832,143 (393)
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
JAMA psychiatry, 2020 This randomized clinical trial examines the efficacy of psilocybin as an adjunct to psychotherapy and other treatments for major depressive disorder.
Alan K. Davis +7 more
semanticscholar +1 more source
Nature Communications, 2021 Major depressive disorder (MDD) has been shown to be associated with structural abnormalities in a variety of spatially diverse brain regions. However, the correlation between brain structural changes in MDD and gene expression is unclear.
Jiao Li +10 more
semanticscholar +1 more source
Journal of Comparative Effectiveness Research, 2023 Aim: Major depressive disorder (MDD) is a debilitating illness in which depressive symptoms may persist after treatment. Treatment inertia is the continued use of the same pharmacotherapy regimen when treatment goals are not met.
John J Sheehan +6 more
doaj +1 more source
Ketamine: A New Antidepressant? [PDF]
Psikiyatride Güncel Yaklaşımlar, 2015 Standart antidepressants are needed for the many individuals with major depressive disorder. However they do not respond adequately to treatment and because of a delay of weeks before the emergence of therapeutic effects.
Feride Karacaer
doaj +1 more source
Disrupted intrinsic functional brain topology in patients with major depressive disorder
Molecular Psychiatry, 2021 Aberrant topological organization of whole-brain networks has been inconsistently reported in studies of patients with major depressive disorder (MDD), reflecting limited sample sizes.
Hong Yang +72 more
semanticscholar +1 more source
Brain and Behavior, 2023 Background The impact of treatment‐resistant depression (TRD) or prior suicidal ideation/suicide attempt (SI/SA) on mortality by suicide among patients with major depressive disorder (MDD) is not well known. This retrospective, observational, descriptive
David M. Kern +7 more
doaj +1 more source
Brain aging in major depressive disorder
European Psychiatry, 2021 Depression and anxiety are common and often comorbid mental health disorders that represent risk factors for aging-related conditions. Brain aging has shown to be more advanced in patients with Major Depressive Disorder (MDD).
L. Han +7 more
doaj +1 more source
Major depressive disorder [PDF]
, 2007 Depression in its various forms is a commonly seen disorder in general practice. Indeed, over 90% of patients suffering from depression are seen, diagnosed and treated in primal) care.
Bonello, Arlene
core +1 more source
Major depressive disorder in detention officers
Revista de Saúde Pública, 2021 OBJECTIVE To identify factors associated with major depressive disorder (MDD) in detention officers. METHODS This cross-sectional study included all detention officers from the largest prison complex in the state of Bahia, Brazil.
Sheila Nascimento Santos +3 more
doaj +2 more sources
Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications
Neuroscience Bulletin, 2021 Major depressive disorder (MDD), also referred to as depression, is one of the most common psychiatric disorders with a high economic burden. The etiology of depression is still not clear, but it is generally believed that MDD is a multifactorial disease
Zezhi Li +3 more
semanticscholar +1 more source